Literature DB >> 19061707

Transcatheter closure of the patent ductus arteriosus using the new Amplatzer duct occluder: initial clinical applications in children.

Basil Thanopoulos1, Nikolaos Eleftherakis, Konstantinos Tzannos, Christodoulos Stefanadis.   

Abstract

BACKGROUND: In spite of recent advances in transcatheter management, the occlusion of certain anatomic types of patent ductus arteriosus (PDA), especially in infants and small children, remains a challenge. The aim of the study was to report initial human experience with transcatheter closure of PDA in 25 patients using the new Amplatzer duct occluder (ADO II) (AGA Medical, Golden Valley, MN).
METHODS: The median age of the patients was 3.2 years (range 0.1-5 years), and the median weight was 10.5 kg (range 3-18 kg). The device used is a modified ADO II made of fabric-free fine Nitinol wire net into 2 very-low-profile disks with an articulated connecting waist. Both disks are 6 mm larger than the diameter of the connecting waist. Connecting waist diameters range from 3 to 6 mm.
RESULTS: The mean PDA diameter was 3.6+/-1.3 mm (range 0.6-5 mm). The mean device diameter (waist diameter) was 4.3+/-1.4 mm (range 3-6 mm). Complete echocardiographic closure of the ductus at 1-month follow-up was observed in 24 (96%) of 25 patients. Immediately after the procedure, there was a mild left pulmonary stenosis (Doppler gradient of 15 mm Hg) in 2 of 25 patients. No other complications were observed.
CONCLUSIONS: The ADO II is a promising addition to our armamentarium for PDA closure. Further studies are required to document its efficacy, safety, and long-term results.

Entities:  

Mesh:

Year:  2008        PMID: 19061707     DOI: 10.1016/j.ahj.2008.08.001

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

1.  Comparison of the efficacy of different-sized Amplatzer duct occluders (I, II, and II AS) in children weighing less than 10 kg.

Authors:  Osman Baspinar; Ahmet Irdem; Ercan Sivasli; Derya Aydin Sahin; Metin Kilinc
Journal:  Pediatr Cardiol       Date:  2012-05-31       Impact factor: 1.655

2.  Transcatheter closure of patent ductus arteriosus in infantile form of Scimitar syndrome with a type II Amplatzer Ductal Occluder.

Authors:  Omar R J Tamimi; Mohammed Al-Ghaihab; Ali A Al Akhfash
Journal:  J Saudi Heart Assoc       Date:  2010-02-24

3.  Estimation of radiation dose and risk to children undergoing cardiac catheterization for the treatment of a congenital heart disease using Monte Carlo simulations.

Authors:  Emmanuel Yakoumakis; Helen Kostopoulou; Triantafilia Makri; Anastastios Dimitriadis; Evaggelos Georgiou; Ioannis Tsalafoutas
Journal:  Pediatr Radiol       Date:  2012-10-24

4.  Transcatheter closure of patent ductus arteriosus and interruption of inferior vena cava with azygous continuation using an Amplatzer duct occluder II.

Authors:  Ghee Tiong Koh; Sharifah Ai Mokthar; Amir Hamzah; Jasvinder Kaur
Journal:  Ann Pediatr Cardiol       Date:  2009-07

5.  Patent ductus arteriosus closure using an Amplatzer(™) ventricular septal defect closure device.

Authors:  Rajeev Fernando; Ketan Koranne; Pranav Loyalka; Biswajit Kar; Igor Gregoric
Journal:  Exp Clin Cardiol       Date:  2013

6.  Percutaneous closure of a moderate to large tubular or elongated patent ductus arteriosus in children younger than 3 years: is the ADO II appropriate?

Authors:  Saktheeswaran Mahesh Kumar; Venkateshwaran Subramanian; Sasidharan Bijulal; Kavassery Mahadevan Krishnamoorthy; Sivasubramonian Sivasankaran; Jaganmohan A Tharakan
Journal:  Pediatr Cardiol       Date:  2013-04-17       Impact factor: 1.655

7.  Ductal closure using the Amplatzer duct occluder type two: experience in Port Elizabeth hospital complex, South Africa: cardiovascular topic.

Authors:  Lungile Pepeta; Adele Dippenaar
Journal:  Cardiovasc J Afr       Date:  2013-07       Impact factor: 1.167

8.  Cost-effectiveness analysis of different devices used for the closure of small-to-medium-sized patent ductus arteriosus in pediatric patients.

Authors:  Sonia A El-Saiedi; Amal M El Sisi; Rodina Sobhy Mandour; Doaa M Abdel-Aziz; Wael A Attia
Journal:  Ann Pediatr Cardiol       Date:  2017 May-Aug
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.